Noom’s GLP-1 Companion Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model
Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect ...
pharmaphorum5d
Noom offers cut-price compounded GLP-1 drug for obesity
Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...
Inc1d
Meet the Fastest-Growing Private Companies in America
Companies on the 2023 Inc. 5000 are ranked according to percentage revenue growth from 2019 to 2022. To qualify, companies must have been founded and generating revenue by March 31, 2019.
pharmaphorum1d
The Ozempic dilemma: Balancing demand, supply, and patient safety in a viral GLP-1 world
As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.
Yahoo Finance2d
Inter & Co, Inc. (INTR)
After hours: January 14 at 6:44:48 PM EST Loading Chart for INTR ...
Yahoo Finance2d
Premier, Inc. (PINC)
After hours: January 14 at 4:37:24 PM EST ...
Inc4d
post-it
They’re the kinds of things very charismatic people use. Here’s how to remember them.
moneycontrol.com2d
Network 18 Media & Investments Ltd.
Note :Financial Information is based on consolidated numbers.